A THIRD-GENERATION HUMAN GUCY2C-TARGETED CAR-T CELL FOR COLORECTAL CANCER IMMUNOTHERAPY

被引：1
|
作者：
Baybutt, Trevor [1 ]
Snook, Adam [1 ]
Waldman, Scott [1 ]
Stem, Jonathan [1 ]
Caparosa, Ellen [1 ]
Zalewski, Alicja [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105
引用
收藏
页码：A65 / A66
页数：2
相关论文
共 50 条
  • [31] EpCAM-targeted CAR-T cell therapy in patients with advanced colorectal and gastric cancers
    Fang, W.
    Luo, T.
    Lu, Z.
    Zhang, H.
    Tong, C.
    Wang, S.
    Tang, F.
    Ai, G.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S880 - S881
  • [32] Effect of CRISPR/Cas9-mediated PD-1-disrupted primary human third-generation CAR-T cells targeting EGFRvIII in human glioblastoma cell growth
    Nakazawa, Tsutomu
    Natsume, Atsushi
    Nishimura, Fumihiko
    Matsuda, Ryosuke
    Nakamura, Mitsutoshi
    Nakagawa, Ichiro
    Motoyama, Yasushi
    Park, Young Soo
    Tsujimura, Takahiro
    Wakabayashi, Toshihiko
    Nakase, Hiroyuki
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [33] HER2-positive gastric cancer: from targeted therapy to CAR-T cell therapy
    Shao, Qiangzu
    Deng, Junge
    Wu, Haoran
    Huang, Zeping
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [34] IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy
    Gu, Aiqin
    Bai, Yue
    Zhang, Can
    Xu, Chang
    An, Zhijing
    Zhang, Ying
    Zhong, Steven H.
    Hu, Yi
    Zhong, Xiaosong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2393 - 2403
  • [35] IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy
    Aiqin Gu
    Yue Bai
    Can Zhang
    Chang Xu
    Zhijing An
    Ying Zhang
    Steven H. Zhong
    Yi Hu
    Xiaosong Zhong
    Cancer Immunology, Immunotherapy, 2023, 72 : 2393 - 2403
  • [36] Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
    Nakazawa, Tsutomu
    Natsume, Atsushi
    Nishimura, Fumihiko
    Morimoto, Takayuki
    Matsuda, Ryosuke
    Nakamura, Mitsutoshi
    Yamada, Shuichi
    Nakagawa, Ichiro
    Motoyama, Yasushi
    Park, Young-Soo
    Tsujimura, Takahiro
    Wakabayashi, Toshihiko
    Nakase, Hiroyuki
    CELLS, 2020, 9 (04)
  • [37] DEVELOPMENT OF GUCY2C-TAC T CELLS FOR THE TREATMENT OF COLORECTAL CANCER
    Benatar, Tania
    Wang, Ling
    Nitya-Nootan, Thanyashanthi
    MacGregor, Heather
    Prosser, Suzanna
    Philbert, I. P.
    Lal, Prabha
    Xu, Stacey
    Shaver, Laura
    Sengupta, Sadhak
    Helsen, Christopher
    Bader, Andreas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A214 - A214
  • [38] PK/PD modeling of CAR-T cell immunotherapy targeted at the cancer-initiating antigen CD44v6
    Bondanza, Attilio
    HUMAN GENE THERAPY, 2014, 25 (11) : A15 - A15
  • [39] Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
    Xia, Xueting
    Yang, Zongxin
    Lu, Qisi
    Liu, Zhenyun
    Wang, Lei
    Du, Jinwen
    Li, Yuhua
    Yang, Dong-Hua
    Wu, Shaojie
    MOLECULAR CANCER, 2024, 23 (01)
  • [40] Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
    Bing-Lan Zhang
    Di-Yuan Qin
    Ze-Ming Mo
    Yi Li
    Wei Wei
    Yong-Sheng Wang
    Wei Wang
    Yu-Quan Wei
    Science China Life Sciences, 2016, 59 : 340 - 348
12345